Fri, November 6, 2020
Thu, November 5, 2020
Wed, November 4, 2020
Tue, November 3, 2020
Mon, November 2, 2020
Sun, November 1, 2020
Fri, October 30, 2020

David Lebowitz Maintained (SNDX) at Hold with Increased Target to $17 on, Nov 4th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-17-on-nov-4th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $16 to $17 on, Nov 4th, 2020.

David, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources